MENU
+Compare
APGE
Stock ticker: NASDAQ
AS OF
Jul 21, 02:48 PM (EDT)
Price
$38.89
Change
-$0.42 (-1.07%)
Capitalization
2.29B

APGE Apogee Therapeutics Forecast, Technical & Fundamental Analysis

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need... Show more

APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for APGE with price predictions
Jul 18, 2025

APGE in upward trend: price expected to rise as it breaks its lower Bollinger Band on July 07, 2025

APGE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 14 cases where APGE's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APGE advanced for three days, in of 123 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 85 cases where APGE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for APGE moved out of overbought territory on July 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on APGE as a result. In of 27 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for APGE turned negative on July 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at .

APGE moved below its 50-day moving average on July 07, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for APGE crossed bearishly below the 50-day moving average on July 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APGE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.404) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). APGE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (270.975).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. APGE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

APGE is expected to report earnings to fall 34.74% to -62 cents per share on September 01

Apogee Therapeutics APGE Stock Earnings Reports
Q2'25
Est.
$-0.62
Q1'25
Missed
by $0.37
Q4'24
Missed
by $0.56
Q3'24
Missed
by $0.30
Q2'24
Missed
by $0.08
The last earnings report on May 12 showed earnings per share of -94 cents, missing the estimate of -57 cents. With 313.04K shares outstanding, the current market capitalization sits at 2.29B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRLFX9.320.01
+0.11%
Hartford Real Asset F
NWCAX60.350.03
+0.05%
Nuveen Winslow Large-Cap Growth ESG A
NMPAX14.42-0.01
-0.07%
Columbia Mid Cap Index Inst
AGVFX26.46-0.03
-0.11%
American Funds Global Insight A
HSLVX46.67-0.41
-0.87%
Hartford Small Cap Growth R6

APGE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+0.79%
SYRE - APGE
53%
Loosely correlated
-3.55%
CRNX - APGE
51%
Loosely correlated
-5.78%
IDYA - APGE
50%
Loosely correlated
-2.26%
ERAS - APGE
49%
Loosely correlated
+0.67%
KRYS - APGE
49%
Loosely correlated
-1.77%
More